- Money Masters
- Posts
- Four Undervalued Companies Gaining Steam
Four Undervalued Companies Gaining Steam
Kenny Goodrich
June 20, 2025
In partnership with
Final Chance to Own a Piece of Virtuix
Virtuix is redefining the future of immersive entertainment — and time is running out to join in. Its flagship “Omni” treadmill lets users physically walk and run in 360 degrees through virtual worlds, with real-world applications across gaming, fitness, and military training.
✅ $18M+ in product sales
✅ 400K+ registered players
✅ 4X revenue growth in the last fiscal year
✅ Backed by $40M+ from top investors, including Shark Tank’s Kevin O’Leary
With over $2.7M raised in this round, investor demand is accelerating — but the raise closes June 20.
This is your final chance to back one of the most exciting players in the VR space.
This Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
THE MONEY IDEA💡
Four Undervalued Companies Gaining Steam
Welcome, we are 30,254 Money Masters and counting!
Even in a market full of noise, quality still rises to the top. These four companies are gaining steam but remain priced below their fair value, offering investors a rare mix of growth and opportunity. Backed by strong fundamentals and industry tailwinds, each stock is worth a closer look this June.
Let’s dive in.
THE MONEY IDEA💡
Four Undervalued Companies Gaining Steam
Industry: Materials / Agricultural Inputs
Current Status: Undervalued; 4-star rating, no moat, high uncertainty
Deep Discount – Shares trade around 30% below fair value, despite recent gains.
Yield Backed by Cash Flow – Pays a 3.5% dividend, supported by integrated retail and wholesale operations.
Potash Rebound – Management reported improving potash margins and healthy demand heading into the second half.
Global Reach – Operates across major farming regions with a strong logistics and supply chain footprint.
Momentum Rising – Stock has rallied over 40% YTD but still appears underpriced relative to long-term potential.
Bottom Line: Nutrien’s combination of improving fundamentals, global scale, and valuation discount make it a standout in the agriculture sector.
Industry: Real Estate / Communications Infrastructure
Current Status: Undervalued; 4-star rating, narrow moat, medium uncertainty
Valuation Support – Trades below Morningstar’s $243 fair value, with room for multiple expansion.
Global Network – Operates more than 260,000 towers and recently expanded into data centers via CoreSite.
Stable Growth – Q1 revenue climbed to $2.56 billion, led by organic tenant billing growth of 4.7%.
Reliable Dividend – Offers a 3% yield with 15 consecutive years of dividend increases.
Solid Balance Sheet – BBB+ credit rating and ~$11.7 billion in liquidity provide flexibility to reduce debt.
Bottom Line: American Tower remains a high-quality dividend grower, with strong global assets and a valuation that still looks attractive.
Industry: Technology / Semiconductor Equipment
Current Status: Undervalued; 4‑star rating, wide moat, high uncertainty
Opportunity After the Drop – Shares have declined significantly but remain below Morningstar’s fair value estimates.
EUV Market Leader – Maintains a near-monopoly in EUV lithography essential for AI and cloud chips.
Capital Returns – Ongoing share buybacks signal strong confidence in long-term prospects.
AI & Cloud Support – Strong demand from data center and AI deployments supports future revenue.
Analyst Confidence – Morningstar expects meaningful long-term growth led by EUV adoption.
Bottom Line: ASML’s unique tech dominance and growth narrative make it a compelling buy below intrinsic value.
Industry: Healthcare / Medical Devices
Current Status: Undervalued; 4‑star rating, wide moat, medium uncertainty
Valuation Gap – Trades approximately 20 % below Morningstar’s $112 fair value.
Wide Moat Advantage – Leading products in heart, diabetes, and neurological care with strong IP.
Income and Growth – Offers a 3.5 % dividend while executing portfolio optimization and spin-offs.
Growth Forecast – Analysts project nearly 5 % annual revenue growth through 2028, supported by buybacks.
Momentum Rebound – Stock has climbed steadily since spring, breaking to new local highs.
Bottom Line: Medtronic offers a blend of resilient income and innovation—trading at an appealing discount.
Need our expert tips? Grab our Money Mastery guides today.
NEWSLETTER CORNER🗞️
Subscribe To Our Friends!
QUOTE CORNER📄
Quote of The Week
How was this newsletter (honestly)? |
Sun’s out, savings out
June is a great time to plan for what FAFSA won’t cover. Compare options, talk with a co-signer, and find a loan that fits your life—from tuition to housing and tech. View Money’s best student loans and apply in minutes to start the fall semester on the right foot.
The Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Reply